ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
IgNova Files Patent Application on Antibody Against COVID-19 americanpharmaceuticalreview
July 03, 2020IgNova has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY).
Pharma Sources Insight January 2025
